The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.
| Date | Insider | Role | Action | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Mar 9, 2026 | Hooks Corwin Dale | Chief Commercial Officer | Grant(A) | 11K | — | $0 |
| Dec 31, 2025 | Szwarcberg Javier B. | CHIEF EXECUTIVE OFFICER, Director | Grant(A) | 5K | $4.53 | $21K |
| Dec 15, 2025 | Gharib Samir M. | PRESIDENT AND CFO | Option exercise(M) | 496 | — | $0 |
| Dec 15, 2025 | Gharib Samir M. | PRESIDENT AND CFO | Tax withholding(F) | 178 | $80.67 | $14K |
| Dec 15, 2025 | Gharib Samir M. | PRESIDENT AND CFO | Option exercise(M) | 513 | — | $0 |
| Dec 15, 2025 | Gharib Samir M. | PRESIDENT AND CFO | Tax withholding(F) | 184 | $80.67 | $15K |
| Dec 15, 2025 | Gharib Samir M. | PRESIDENT AND CFO | Option exercise(M) | 513 | — | $0 |
| Dec 15, 2025 | Gharib Samir M. | PRESIDENT AND CFO | Option exercise(M) | 496 | — | $0 |
| Dec 15, 2025 | Szwarcberg Javier B. | CHIEF EXECUTIVE OFFICER, Director | Tax withholding(F) | 752 | $80.67 | $61K |
| Dec 15, 2025 | Szwarcberg Javier B. | CHIEF EXECUTIVE OFFICER, Director | Tax withholding(F) | 608 | $80.67 | $49K |
| Dec 15, 2025 | Szwarcberg Javier B. | CHIEF EXECUTIVE OFFICER, Director | Option exercise(M) | 1K | — | $0 |
| Dec 15, 2025 | Szwarcberg Javier B. | CHIEF EXECUTIVE OFFICER, Director | Option exercise(M) | 1K | — | $0 |
| Dec 15, 2025 | Szwarcberg Javier B. | CHIEF EXECUTIVE OFFICER, Director | Option exercise(M) | 1K | — | $0 |
| Dec 15, 2025 | Szwarcberg Javier B. | CHIEF EXECUTIVE OFFICER, Director | Option exercise(M) | 1K | — | $0 |
| Dec 11, 2025 | Ways Douglas Kirk | Interim Chief Medical Officer, Director | Option exercise(M) | 1K | — | $0 |
| Dec 11, 2025 | Ways Douglas Kirk | Interim Chief Medical Officer, Director | Option exercise(M) | 1K | — | $0 |
| Dec 11, 2025 | Ways Douglas Kirk | Interim Chief Medical Officer, Director | Grant(A) | 5K | — | $0 |
| Dec 11, 2025 | Ways Douglas Kirk | Interim Chief Medical Officer, Director | Grant(A) | 266 | — | — |
| Dec 11, 2025 | Ways Douglas Kirk | Interim Chief Medical Officer, Director | Disposed to issuer(D) | 266 | — | — |
| Dec 11, 2025 | Ways Douglas Kirk | Interim Chief Medical Officer, Director | Grant(A) | 400 | — | — |
| Dec 11, 2025 | Ways Douglas Kirk | Interim Chief Medical Officer, Director | Disposed to issuer(D) | 400 | — | — |
| Dec 11, 2025 | Spiegelman Daniel K | Director | Disposed to issuer(D) | 88 | — | — |
| Dec 11, 2025 | Spiegelman Daniel K | Director | Grant(A) | 400 | — | — |
| Dec 11, 2025 | Spiegelman Daniel K | Director | Grant(A) | 88 | — | — |
| Dec 11, 2025 | Spiegelman Daniel K | Director | Grant(A) | 458 | — | — |
| Dec 11, 2025 | Spiegelman Daniel K | Director | Disposed to issuer(D) | 458 | — | — |
| Dec 11, 2025 | Spiegelman Daniel K | Director | Disposed to issuer(D) | 400 | — | — |
| Dec 11, 2025 | Grey Michael G | Executive Chairman, Director | Disposed to issuer(D) | 666 | — | — |
| Dec 11, 2025 | Grey Michael G | Executive Chairman, Director | Grant(A) | 400 | — | — |
| Dec 11, 2025 | Grey Michael G | Executive Chairman, Director | Disposed to issuer(D) | 400 | — | — |
| Dec 11, 2025 | Grey Michael G | Executive Chairman, Director | Grant(A) | 387 | — | — |
| Dec 11, 2025 | Grey Michael G | Executive Chairman, Director | Disposed to issuer(D) | 387 | — | — |
| Dec 11, 2025 | Grey Michael G | Executive Chairman, Director | Grant(A) | 1K | — | — |
| Dec 11, 2025 | Grey Michael G | Executive Chairman, Director | Disposed to issuer(D) | 1K | — | — |
| Dec 11, 2025 | Grey Michael G | Executive Chairman, Director | Grant(A) | 1K | — | — |
| Dec 11, 2025 | Grey Michael G | Executive Chairman, Director | Disposed to issuer(D) | 1K | — | — |
| Dec 11, 2025 | Grey Michael G | Executive Chairman, Director | Grant(A) | 133 | — | — |
| Dec 11, 2025 | Grey Michael G | Executive Chairman, Director | Disposed to issuer(D) | 133 | — | — |
| Dec 11, 2025 | Grey Michael G | Executive Chairman, Director | Grant(A) | 666 | — | — |
| Dec 11, 2025 | Gharib Samir M. | PRESIDENT AND CFO | Option exercise(M) | 2K | — | $0 |
| Dec 11, 2025 | Gharib Samir M. | PRESIDENT AND CFO | Tax withholding(F) | 680 | $88.41 | $60K |
| Dec 11, 2025 | Gharib Samir M. | PRESIDENT AND CFO | Option exercise(M) | 2K | — | $0 |
| Dec 11, 2025 | Gharib Samir M. | PRESIDENT AND CFO | Grant(A) | 8K | — | $0 |
| Dec 11, 2025 | Gharib Samir M. | PRESIDENT AND CFO | Grant(A) | 2K | — | — |
| Dec 11, 2025 | Gharib Samir M. | PRESIDENT AND CFO | Disposed to issuer(D) | 2K | — | — |
| Dec 11, 2025 | Gharib Samir M. | PRESIDENT AND CFO | Grant(A) | 953 | — | — |
| Dec 11, 2025 | Gharib Samir M. | PRESIDENT AND CFO | Disposed to issuer(D) | 953 | — | — |
| Dec 11, 2025 | Gharib Samir M. | PRESIDENT AND CFO | Disposed to issuer(D) | 933 | — | — |
| Dec 11, 2025 | Gharib Samir M. | PRESIDENT AND CFO | Disposed to issuer(D) | 733 | — | — |
| Dec 11, 2025 | Gharib Samir M. | PRESIDENT AND CFO | Grant(A) | 2K | — | — |
| Dec 11, 2025 | Gharib Samir M. | PRESIDENT AND CFO | Disposed to issuer(D) | 2K | — | — |
| Dec 11, 2025 | Gharib Samir M. | PRESIDENT AND CFO | Grant(A) | 933 | — | — |
| Dec 11, 2025 | Gharib Samir M. | PRESIDENT AND CFO | Grant(A) | 733 | — | — |
| Dec 11, 2025 | Simpson Camilla V | Director | Grant(A) | 173 | — | — |
| Dec 11, 2025 | Simpson Camilla V | Director | Disposed to issuer(D) | 173 | — | — |
| Dec 11, 2025 | Simpson Camilla V | Director | Grant(A) | 309 | — | — |
| Dec 11, 2025 | Simpson Camilla V | Director | Disposed to issuer(D) | 309 | — | — |
| Dec 11, 2025 | Simpson Camilla V | Director | Disposed to issuer(D) | 400 | — | — |
| Dec 11, 2025 | Simpson Camilla V | Director | Disposed to issuer(D) | 362 | — | — |
| Dec 11, 2025 | Simpson Camilla V | Director | Grant(A) | 133 | — | — |
| Dec 11, 2025 | Simpson Camilla V | Director | Disposed to issuer(D) | 133 | — | — |
| Dec 11, 2025 | Simpson Camilla V | Director | Grant(A) | 400 | — | — |
| Dec 11, 2025 | Simpson Camilla V | Director | Grant(A) | 362 | — | — |
| Dec 11, 2025 | Szwarcberg Javier B. | CHIEF EXECUTIVE OFFICER, Director | Tax withholding(F) | 2K | $88.41 | $194K |
| Dec 11, 2025 | Szwarcberg Javier B. | CHIEF EXECUTIVE OFFICER, Director | Option exercise(M) | 5K | — | $0 |
| Dec 11, 2025 | Szwarcberg Javier B. | CHIEF EXECUTIVE OFFICER, Director | Grant(A) | 20K | — | $0 |
| Dec 11, 2025 | Szwarcberg Javier B. | CHIEF EXECUTIVE OFFICER, Director | Option exercise(M) | 5K | — | $0 |
| Dec 11, 2025 | Szwarcberg Javier B. | CHIEF EXECUTIVE OFFICER, Director | Grant(A) | 10K | — | — |
| Dec 11, 2025 | Szwarcberg Javier B. | CHIEF EXECUTIVE OFFICER, Director | Disposed to issuer(D) | 10K | — | — |
| Dec 11, 2025 | Szwarcberg Javier B. | CHIEF EXECUTIVE OFFICER, Director | Grant(A) | 2K | — | — |
| Dec 11, 2025 | Szwarcberg Javier B. | CHIEF EXECUTIVE OFFICER, Director | Disposed to issuer(D) | 2K | — | — |
| Dec 11, 2025 | Barretto-Ko Percival | Director | Disposed to issuer(D) | 800 | — | — |
| Dec 11, 2025 | Barretto-Ko Percival | Director | Grant(A) | 800 | — | — |
| Dec 11, 2025 | Walbert Keli | Director | Grant(A) | 3K | — | $0 |
| Dec 10, 2025 | Gharib Samir M. | PRESIDENT AND CFO | Option exercise(M) | 514 | — | $0 |
| Dec 10, 2025 | Gharib Samir M. | PRESIDENT AND CFO | Tax withholding(F) | 184 | $85.67 | $16K |
| Dec 10, 2025 | Gharib Samir M. | PRESIDENT AND CFO | Option exercise(M) | 514 | — | $0 |
| Dec 10, 2025 | Szwarcberg Javier B. | CHIEF EXECUTIVE OFFICER, Director | Tax withholding(F) | 428 | $85.67 | $37K |
| Dec 10, 2025 | Szwarcberg Javier B. | CHIEF EXECUTIVE OFFICER, Director | Option exercise(M) | 1K | — | $0 |
| Dec 10, 2025 | Szwarcberg Javier B. | CHIEF EXECUTIVE OFFICER, Director | Option exercise(M) | 1K | — | $0 |
| Oct 20, 2025 | Gharib Samir M. | PRESIDENT AND CFO | Option exercise(M) | 2K | — | $0 |
| Oct 20, 2025 | Gharib Samir M. | PRESIDENT AND CFO | Tax withholding(F) | 661 | $148.16 | $98K |
| Oct 20, 2025 | Gharib Samir M. | PRESIDENT AND CFO | Grant(A) | 2K | — | $0 |
| Oct 20, 2025 | Gharib Samir M. | PRESIDENT AND CFO | Option exercise(M) | 2K | — | $0 |
| Oct 20, 2025 | Szwarcberg Javier B. | CHIEF EXECUTIVE OFFICER, Director | Option exercise(M) | 5K | — | $0 |
| Oct 20, 2025 | Szwarcberg Javier B. | CHIEF EXECUTIVE OFFICER, Director | Tax withholding(F) | 2K | $148.16 | $228K |
| Oct 20, 2025 | Szwarcberg Javier B. | CHIEF EXECUTIVE OFFICER, Director | Option exercise(M) | 5K | — | $0 |
| Oct 20, 2025 | Szwarcberg Javier B. | CHIEF EXECUTIVE OFFICER, Director | Grant(A) | 5K | — | $0 |
| Oct 6, 2025 | Parkman Healthcare Partners LLC | 10% Owner | Sell(S) | 232 | $19.33 | $4K |
| Oct 6, 2025 | Parkman Healthcare Partners LLC | 10% Owner | Sell(S) | 25 | $17.46 | $437 |
| Oct 6, 2025 | Parkman Healthcare Partners LLC | 10% Owner | Buy(P) | 256 | $17.91 | $5K |
| Oct 6, 2025 | Parkman Healthcare Partners LLC | 10% Owner | Sell(S) | 232 | $19.33 | $4K |
| Oct 6, 2025 | Parkman Healthcare Partners LLC | 10% Owner | Buy(P) | 256 | $17.91 | $5K |
| Oct 6, 2025 | Parkman Healthcare Partners LLC | 10% Owner | Sell(S) | 25 | $17.46 | $437 |
| Jul 23, 2025 | Ways Kirk | Interim Chief Medical Officer, Director | Grant(A) | 30K | — | $0 |
| Jul 22, 2025 | Muralidhar Bali | Director | Grant(A) | 30K | — | $0 |
| Jul 22, 2025 | Aynechi Tiba | Director | Grant(A) | 30K | — | $0 |
| Jul 22, 2025 | Barretto-Ko Percival | Director | Grant(A) | 30K | — | $0 |
| Jul 22, 2025 | Grey Michael G | Executive Chairman, Director | Grant(A) | 30K | — | $0 |
| Jul 22, 2025 | Simpson Camilla V | Director | Grant(A) | 30K | — | $0 |
Insider transactions sourced from SEC EDGAR Form 4 filings, normalized within minutes of acceptance. "Buy"/"Sell" mark open-market transactions (codes P/S), the tradeable signal. Awards, option exercises and tax-withholding are shown with their raw code. All data is public domain.
Programmatic access via the Arkolith API & MCP server (insider.transactions, insider.company).